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Candida albicans is an opportunistic fungal able to produces both superficial and systemic infections in 
immunocompromised patients. It has been demonstrated that biofilms produced by C. albicans are resistant to 
different antifungal drugs and, that, the infections related to biofilm formation are, frequently, refractory to the 
conventional treatments. Photodynamic antimicrobial chemotherapy (PACT) is a potential antimicrobial therapy, 
which combines visible light and a nontoxic dye, known as a photosensitizer, producing ROS, which can kill the 
treated cells. In this work, we investigate the effects of PACT, using Toluidine blue (TB), as a photosensitizer on 
24 hour old biofilms produced by C. albicans. It was observed that PACT, using TB was able to decrease the 
viability of the 24 hour old biofilms produced, in a TB concentration dependent manner. The inhibition promoted 
by PACT (0.1 mg/ml TB) was in the order of 30%, 40% and 50% in 24 hour old biofilms submitted to incubation 
times of 1, 2 and 3 hours, after PACT, respectively. At the same time, the increase in the ROS production was 
observed after PACT. Our results suggest that the inhibition observed in the viability of the 24 hour old biofilms, 
by PACT, can be related to the increase in ROS production, increasing the cell permeability and leading to the 
damage in 24 hour old biofilms produced by C. albicans.
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Cystic Fibrosis (CF) is characterized by high rates of morbidity and mortality caused by pulmonary microbial 
infections. Pseudomonas aeruginosa is typically the prevailing pathogen in the airways of CF patients. However, 
an emergent and diverse microbial community inhabiting CF lungs has been disclosed, but how it interacts and 
contributes to the polymicrobial consortia with CF-common pathogens is still to be revealed.
The mail goal of this study was to address the behavior of two CF-atypical bacteria, Inquilinus limosus (IL) and 
Dolosigranulum pigrum (DP), when associated to P. aeruginosa (PA) under oxygen-atmospheres resembling CF 
airways. For this, those bacteria were grown in dual- and three-species populations with P. aeruginosa in 
variable oxygen conditions and biofilms were thoroughly characterized for biomass, activity, CFU numbers, 
antibiotic resistance profiles and relative distributions of bacterial populations.  
Dual-species consortia were of difficult eradication, with most antibiotics being ineffective in reducing biofilm-
bacteria, particularly under low-oxygen atmospheres. Regarding microbial composition, these biofilms presented 
similar bacterial proportions, whereas P. aeruginosa and D. pigrum dominated the three-species consortia, with I.
limosus being the smallest representative population. In general, biofilm compositions changed as a result of 
antibiotic treatment, with alterations being dependent on the antibiotic, concentration and oxygen condition 
implemented. P. aeruginosa and I. limosus dual-biofilms exhibited higher antibiotic resistance, with I. limosus
persisting and occupying a significant portion together with P. aeruginosa in the overall biofilm after antibiotic 
treatment. Interestingly, the three-species biofilms displayed higher sensitivity, with D. pigrum and/or P.
aeruginosa dominating and I. limosus populations declining in most cases. This suggests that the preponderance 
of D. pigrum in the biofilm was decisive to decrease I. limosus and lead to an increase in overall sensitivity of the 
biofilm to a large number of antibiotics. PNA FISH allowed the direct observation of the location and 
distribution of the three-species species within the biofilms, corroborating the dominance of D. pigrum and P. 
aeruginosa within the mixed-species consortia and facilitating the understanding of the real complex interactions 
among the bacterial species.  
Data highlighted that emergent species are able to establish polymicrobial consortia with common pathogens in 
the airways of CF patients, modulating different social activities into those communities and impacting the CF 
therapeutics.
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